These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1139664)

  • 1. [Immunologic manifestations in the serum of patients with malignant diseases].
    Konopík J; Chaloupecká P; Kohout P; Jakoubková J; Lintner L
    Cesk Dermatol; 1975 Jun; 50(3):169-73. PubMed ID: 1139664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of the IgM-level in serum of patients with tumors].
    Göring HD; Schubert H; Raith L
    Dermatol Monatsschr; 1975 Aug; 161(8):640-5. PubMed ID: 1204919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection and characterization of human tumor-associated antigens].
    Gupta RK
    Medicina (B Aires); 1988; 48(6):695-705. PubMed ID: 2687618
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
    Oka Y; Tsuboi A; Sugiyama H
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current problems in immunology].
    Ambrosius H
    Z Gesamte Inn Med; 1974 Apr; 29(8):309-15. PubMed ID: 4137395
    [No Abstract]   [Full Text] [Related]  

  • 6. Auto-antibodies in malignant disease.
    Whitehouse JM; Fairley G
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):197-202. PubMed ID: 4589246
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.
    Brändlein S; Pohle T; Ruoff N; Wozniak E; Müller-Hermelink HK; Vollmers HP
    Cancer Res; 2003 Nov; 63(22):7995-8005. PubMed ID: 14633732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
    Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
    Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum immunoglobulin levels in cancer patients. II. Serum immunoglobulins and stage of tumor progress.
    Dostálová O; Schön E; Wagnerová M; Jelínek J; Wagner V
    Neoplasma; 1976; 23(1):95-102. PubMed ID: 1272476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural IgM antibodies, the ignored weapons in tumour immunity.
    Brändlein S; Vollmers HP
    Histol Histopathol; 2004 Jul; 19(3):897-905. PubMed ID: 15168352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating IgG-containing immune complexes in malignant growth].
    Kostrzhevskaia EG
    Eksp Onkol; 1986; 8(3):10-7. PubMed ID: 2424714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulin levels in cancer patients. I. Serum immunoglobulins and primary tumor localization.
    Dostálová O; Schön E; Wagnerová M; Jelínek J; Wagner V
    Neoplasma; 1975; 22(5):539-46. PubMed ID: 1196438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 antibodies in patients with various types of cancer: assay, identification, and characterization.
    Lubin R; Schlichtholz B; Teillaud JL; Garay E; Bussel A; Wild CP
    Clin Cancer Res; 1995 Dec; 1(12):1463-9. PubMed ID: 9815945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Binding of IgG and IgM class antibodies from the serum of patients with ovarian carcinoma to malignant and normal ovaries].
    Stankus P; Gazárek F
    Cesk Gynekol; 1983 Jun; 48(5):332-8. PubMed ID: 6352065
    [No Abstract]   [Full Text] [Related]  

  • 15. Basic principles of the immune response and the immunologic inhibition of tumors.
    Vorlaender KO
    Allergol Immunopathol (Madr); 1973 Jul; 1(4):235-46. PubMed ID: 4794103
    [No Abstract]   [Full Text] [Related]  

  • 16. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients.
    Brändlein S; Lorenz J; Ruoff N; Hensel F; Beyer I; Müller J; Neukam K; Illert B; Eck M; Müller-Hermelink HK; Vollmers HP
    Hum Antibodies; 2002; 11(4):107-19. PubMed ID: 12775891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia].
    López Nevot MA; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F
    Sangre (Barc); 1986; 31(6):751-8. PubMed ID: 3551142
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation, purification and identification of a serum DNA binding protein which increases in malignant diseases.
    Ohkubo T; Tsuda M; Yamamura M; Matsumoto M; Kamiguchi H; Katsunuma T
    Tokai J Exp Clin Med; 1982 May; 7(3):331-6. PubMed ID: 6896936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cancer-immunity relation].
    Sáiz García F; Rodríqez Valverde V; Agüero Balbín R
    Rev Clin Esp; 1982 Feb; 164(4):219-23. PubMed ID: 7089344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.